Tag: National Institute for Health and Care Excellence (NICE)
New NICE recommended migraine pill to help 170k patients
Migraine affects a total of 4.5 million people in the UKÂ Â
Patients suffering from chronic and episodic migraine attacks are set to benefit from a...
New NHS ADHD Taskforce to partner with ICBs, PCS, Clinical Teams
Post-covid the NHS received an astounding 4.3 million page views related to ADHD
A new Attention-Deficit-Hyperactive disorder (ADHD) taskforce has been launched by National Health...
Community pharmacies to provide free COVID-19 tests to eligible patients
The new Advanced service to supply Lateral Flow Device (LFD) kits through pharmacists is set to launch next month
The Department of Health and Social...
NICE recommends new treatment for urothelial cancer
The National Institute for Health and Care Excellence (NICE) has recommended a new treatment, ‘avelumab’, for metastatic urothelial cancer.
The recommendation follows a successful appeal...
NICE recommends Forxiga to treat chronic kidney disease
The National Institute for Health and Care Excellence (NICE) today issued a draft guidance recommending dapagliflozin, sold under the brand name Forxiga among others,...
NICE announces roundtable to discuss myalgic encephalomyelitis
After the pause to the publication of the guideline about myalgic encephalomyelitis (also known as chronic fatigue syndrome), the National Institute for Health and...